EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment

John G Mina iD, Anutthaman Parthasarathy iD, Exequiel O Porta iD, Paul W Denny iD, Karunakaran Kalesh iD

Pathogens · 2024

DOI: 10.3390/pathogens13100879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von John G Mina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Syngenta International Research Centre, Jealott's Hall, Bracknell, Berkshire RG42 6EY, UK. Hauptthemen laut MEDLINE: Pyrimethamine, Toxoplasma, Protozoan Proteins. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Research and Innovation, Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We employed a BONCAT-iTRAQ labelling approach to investigate newly synthesised proteins (NSPs) in Toxoplasma gondii subjected to varying concentrations of the antifolate drug pyrimethamine. Our results reveal that numerous NSPs exhibited altered expression levels in response to the drug, with significant upregulation observed at higher concentrations. Key proteins involved in protein synthesis, stress responses, energy metabolism, and cytoskeletal dynamics were identified, indicating that T. gondii undergoes complex adaptive responses to pyrimethamine treatment. While some of the identified pathways reflect a generic stress response, this study provides important molecular markers and mechanistic insights specific to the parasite’s adaptation strategies. These findings contribute to understanding how T. gondii modulates its proteome in response to drug-induced stress and lay the groundwork for further investigations into potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimethamineToxoplasmaProtozoan ProteinsAdaptation, PhysiologicalProteomeAntiprotozoal AgentsProteomicsBiomarkersStress, Physiological

Stichwörter der Autor:innen

BONCATToxoplasma gondiiiTRAQpyrimethaminequantitative proteomics

Substanzen

PyrimethamineProtozoan ProteinsProteomeAntiprotozoal AgentsBiomarkers

Autor:innen und Institutionen

  • Syngenta International Research Centre, Jealott's Hall, Bracknell, Berkshire RG42 6EY, UK.
  • School of Chemistry and Life Sciences, Richmond Building, University of Bradford, Bradford BD7 1DP, UK.
  • School of Pharmacy, University College London, London WC1N 1AX, UK.
  • Department of Biosciences, Durham University, Durham DH1 3LE, UK.
  • School of Health and Life Sciences, Teesside University, Middlesbrough TS1 3BX, UK.
  • National Horizons Centre, 38 John Dixon Lane, Darlington DL1 1HG, UK.

ORCID-Profile: John G Mina, Anutthaman Parthasarathy, Exequiel O Porta, Paul W Denny, Karunakaran Kalesh

Förderung

  • UK Research and Innovation
  • Royal Society

Zitieren

APA

Mina, J. G., Parthasarathy, A., Porta, E. O., Denny, P. W., & Kalesh, K. (2024). BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment. Pathogens. https://doi.org/10.3390/pathogens13100879

Vancouver

Mina JG, Parthasarathy A, Porta EO, Denny PW, Kalesh K. BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment. Pathogens. 2024. doi:10.3390/pathogens13100879

BibTeX
@article{Mina2024,
  author = {Mina, John G and Parthasarathy, Anutthaman and Porta, Exequiel O and Denny, Paul W and Kalesh, Karunakaran},
  title = {BONCAT-iTRAQ Labelling Reveals Molecular Markers of Adaptive Responses in Toxoplasma gondii to Pyrimethamine Treatment},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13100879}
}
Kostenlos starten →